Editorial: Extending the frontiers of cardiac magnetic resonance

Circulation

Volumn 118, Issue 2, 2008, Pages 109-112

  Schwitter, Juerg ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Contrast media; Editorials; Imaging; Magnetic resonance imaging; Metabolism; Spectroscopy

Indexed keywords

CARBON 13; CONTRAST MEDIUM; FLUORINE; FLUOROCARBON; GADOLINIUM; HYDROGEN; PYRUVIC ACID; ISOTOPE;

CARDIOVASCULAR SYSTEM; CHELATION; CITRIC ACID CYCLE; CONGESTIVE HEART FAILURE; ECHOCARDIOGRAPHY; EDITORIAL; FLUORINE NUCLEAR MAGNETIC RESONANCE; HEART PERFUSION; HUMAN; HYPERPOLARIZATION; INFLAMMATION; MOLECULAR IMAGING; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; RADIOSENSITIVITY; SENSITIVITY AND SPECIFICITY; SIGNAL NOISE RATIO; SIGNAL PROCESSING; ANIMAL; CARDIOVASCULAR SYSTEM EXAMINATION; METHODOLOGY; NOTE; PATHOLOGY;

ANIMALS; DIAGNOSTIC TECHNIQUES, CARDIOVASCULAR; HUMANS; INFLAMMATION; ISOTOPES; MAGNETIC RESONANCE IMAGING;

EID: 47649132486     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.108.790139     Document Type: Editorial

References (21)

1. Flögel V, Ding Z, Hardung H, Jander S, Reichmann G, Jacoby C, Schubert R, Schrader J. In vivo monitoring of inflammation after cardiac and cerebral ischemia by fluorine magnetic resonance imaging. Circulation. 2008;118:140-148.
2. Ardenkjaer-Larsen J, Fridlund B, Gram A, Hansson G, Hansson L, Lerche M, Servin R, Thaning M, Golman K. Increase in signal-to-noise ratio of >10 000 times in liquid-state NMR. Proc Natl Acad Sci USA. 2003;100:10158-10163.
3. 13C1-pyruvate affect metabolic results in dog prostate? Paper presented at:16th Scientific Meeting of ISMRM; May 3-9, 2008; Toronto, Canada. Abstract 172.
4. Golman K, in't Zandt R, Thaning M. Real-time metabolic imaging. Proc Natl Acad Sci U SA. 2006;103:11270-11275.
5. Louie A, Hueber M, Ahrens E, Rothbaecher U, Moats R, Jacobs R, Fraser S, Meade T. In vivo visualization of gene expression using magnetic resonance imaging. Nat Biotechnol. 2000;18:321-325.
6. Schwitter J. Myocardial perfusion imaging by cardiac magnetic resonance. J Nucl Cardiol. 2006;13:841-854.
7. Opie L. The metabolic vicious cycle in heart failure. Lancet. 2004;364:1733-1734.
8. Murray A, Anderson R, Watson G, Radda G, Clarke K. Uncoupling proteins in human heart. Lancet. 2004;364:1786-1788.
9. Jaffer F, Weissleder R. Seeing within:molecular imaging of the cardiovascular system. Circ Res. 2004;94:433-445.
10. Balaban R, Arai A. Function, metabolic, and flow heterogeneity of the heart:the view is getting better. Circ Res. 2001;88:265-267.
11. Johansson L, Bjoernerud A, Ahlstroem H, Ladd D, Fujii D. A targeted contrast agent for magnetic resonance imaging of thrombus:implications of spatial resolution. J Magn Reson Imaging. 2001;13:615-618.
12. Mansson S, Johansson E, Magnusson P, Chai C, Petersson J, Stahlberg F, Golman K. 13-C imaging:a new diagnostic platform. Eur Radiol. 2006; 16:57-67.
13. Schwitter J, Nanz D, Kneifel S, Bertschinger K, Biichi M, Kniïsel PR, Marincek B, Liischer TF, von Schulthess GK. Assessment of myocardial perfusion in coronary artery disease by magnetic resonance:a comparison with positron emission tomography and coronary angiography. Circulation. 2001;103:2230-2235.
14. Schwitter J, Wacker C, van Rossum A, Lombardi M, Al-Saadi N, Ahlstrom H, Dill T, Larsson HB, Flamm S, Marquardt M, Johansson L. MR-IMPACT:comparison of perfusion-cardiac magnetic resonance with single-photon emission computed tomography for the detection of coronary artery disease in a multicentre, multivendor, randomized trial. Eur Heart J. 2008;29:480-489.
15. Kim RJ, Wu E, Rafael A, Chen EL, Parker MA, Simonetti O, Klocke FJ, Bonow RO, Judd RM. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med. 2000;343:1445-1453.
16. Schwitter J, DeMarco T, Kneifel S, von Schulthess GK, Jörg MC, Arheden H, Rühm S, Stumpe K, Buck A, Parmley WW, Liischer TF, Higgins CB. Magnetic resonance-based assessment of global coronary flow and flow reserve and its relation to left ventricular functional parameters:a comparison with positron emission tomography. Circulation. 2000;101:2696-2702.
17. Sorensen MB, Collins P, Ong PJ, Webb CM, Hayward CS, Asbury EA, Gatehouse PD, Elkington AG, Yang GZ, Kubba A, Pennel DJ. Long-term use of contraceptive depot medroxyprogesterone acetate in young women impairs arterial endothelial function assessed by cardiovascular magnetic resonance. Circulation. 2002;106:1646-1651.
18. Silber HA, Bluemke DA, Ouyang P, Du YP, Post WS, Lima JA. The relationship between vascular wall shear stress and flow-mediated dilation:endothelial function assessed by phase-contrast magnetic resonance angiography. J Am Coll Cardiol. 2001;38:1859-1865.
19. Schwitter J, Oelhafen M, Wyss BM, Kozerke S, Amann-Vesti B, Lüscher TF, Boesiger P. 2D-spatially-selective real-time magnetic resonance imaging for the assessment of microvascular function and its relation to the cardiovascular risk profile. J Cardiovasc Magn Reson. 2006;8:759 -769.
20. Winter PM, Morawski AM, Caruthers SD, Fuhrhop RW, Zhang H, Williams TA, Allen JS, Lacy EK, Robertson JD, Lanza GM, Wickline SA. Molecular imaging of angiogenesis in early-stage atherosclerosis with alpha(v) beta3-integrin- targeted nanoparticles. Circulation. 2003; 108:2270-2274.
21. Hill J, Dick A, Raman V, Thompson R, Yu Z, Hinds K, Pessanha B, Guttman M, Varney T, Martin B, Dunbar C, McVeigh E, Lederman R. Serial cardiac magnetic resonance imaging of injected mesenchymal stem cells. Circulation. 2003;108:1009-1014.